Almirall (OTCMKTS:LBTSF – Get Free Report) is expected to be posting its resultson Friday, July 24th. Analysts expect Almirall to post earnings of $0.1485 per share and revenue of $357.6250 million for the quarter.
Almirall Price Performance
Shares of LBTSF opened at $15.35 on Friday. The business’s 50 day moving average price is $15.35 and its 200-day moving average price is $15.38. Almirall has a 52 week low of $13.36 and a 52 week high of $15.47.
Almirall Company Profile
Almirall is a research-driven pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943, the firm has evolved into a specialist in dermatology, dedicating its efforts to understanding and treating a range of inflammatory and chronic skin conditions. Over the decades, Almirall has built a reputation for its targeted R&D approach and its commitment to improving patient outcomes in dermatological care.
The company’s core activities span the research, development, manufacturing and marketing of prescription therapies for skin diseases.
Further Reading
- Five stocks we like better than Almirall
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Almirall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almirall and related companies with MarketBeat.com's FREE daily email newsletter.
